SMARTDIAB: a communication and information technology approach for the intelligent monitoring, management and follow-up of type 1 diabetes patients

Development and Validation of Binary Classifiers to Predict Nocturnal Hypoglycemia in Adults With Type 1 Diabetes

BACKGROUND

One of the biggest challenges for people with type 1 diabetes (T1D) using multiple daily injections (MDIs) is nocturnal hypoglycemia (NH). Recurrent NH can lead to serious complications; hence, prevention is of high importance. In this work, we develop and externally validate, device-agnostic Machine Learning (ML) models to provide bedtime decision support to people with T1D and minimize the risk of NH.

METHODS

We present the design and development of binary classifiers to predict NH (blood glucose levels occurring below 70 mg/dL). Using data collected from a 6-month study of 37 adult participants with T1D under free-living conditions, we extract daytime features from continuous glucose monitor (CGM) sensors, administered insulin, meal, and physical activity information. We use these features to train and test the performance of two ML algorithms: Random Forests (RF) and Support Vector Machines (SVMs). We further evaluate our model in an external population of 20 adults with T1D using MDI insulin therapy and wearing CGM and flash glucose monitoring sensors for two periods of eight weeks each.

RESULTS

At population-level, SVM outperforms RF algorithm with a receiver operating characteristic-area under curve (ROC-AUC) of 79.36% (95% CI: 76.86%, 81.86%). The proposed SVM model generalizes well in an unseen population (ROC-AUC = 77.06%), as well as between the two different glucose sensors (ROC-AUC = 77.74%).

CONCLUSIONS

Our model shows state-of-the-art performance, generalizability, and robustness in sensor devices from different manufacturers. We believe it is a potential viable approach to inform people with T1D about their risk of NH before it occurs.

A Smart Monitoring System for Self-Nutrition Management in Pediatric Patients with Inherited Metabolic Disorders: Maple Syrup Urine Disease (MSUD)

A metabolic disorder is due to a gene mutation that causes an enzyme deficiency which leads to metabolism problems. Maple Syrup Urine Disease (MSUD) is one of the most common and severe hereditary metabolic disorders in Saudi Arabia. Patients and families were burdened by complex and regular dietary therapy menus because of the lack of information on food labels, it was also difficult to keep track of MSUD's typical diet. The prototype smart plate system proposed in this work may help patients with MSUD and their caregivers better manage the patients' MSUD diet. The use of knowledge-based, food identification techniques and a device could provide a support tool for self-nutrition management in pediatric patients. The requirements of the system are specified by using questionaries. The design of the prototype is divided into two parts: software (mobile application) and hardware (3D model of the plate). The knowledge-based mobile application contains knowledge, databases, inference, food recognition, food plan, monitor food plan, and user interfaces. The hardware prototype is represented in a 3D model. All the patients agreed that a smart plate system connected to a mobile application could help to track and record their daily diet. A self-management application can help MSUD patients manage their diet in a way that is more pleasant, effortless, accurate, and intelligent than was previously possible with paper records. This could support dietetic professional practitioners and their patients to achieve sustainable results.

PwCOV in cluster-based web server

In this work, we are introducing a novel assessment methodology for evaluating a prototype web service–based system for COVID-19 disease processing system by using cluster-based web server. We call it as PwCOV. The service generates clinical instructions and process respective information for distributed disease data sets. It follows the business processes and principles of service-oriented computing for each end user request. The assessment methodology illustrates different aspects of service deployment for massive growth of service users. In this study, the PwCOV is observed to be stable up to the stress level of 1700 simultaneous users. The response time of 14.35 s, throughput of 8592 bytes/s, and central processing unit (CPU) utilization of 22.16% with a strong reliability of service execution is observed. However, the reliability of PwCOV execution degrades beyond that execution limit. For 1800 simultaneous users of the service, the response time, throughput and CPU utilization is recorded to be 25.28 s, 15,729 bytes/s, and 39.13%, respectively. During this stress, the service failure rate of 35% is observed. A moderate reliability of 70% of service period is observed for 1800 users. The propose study also discusses the impact of system metric, reliability, and their correlation over the service execution. The statistical analysis is carried out to study the viability, acceptability, applicability of such deployment for COVID-19 disease processing system. The limitation of PwCOV for processing geographically scattered data sets is also discussed.

Medical software applications for in-hospital insulin therapy: A systematic review

Background

In-hospital hyperglycemia (HH) is frequent and related to higher morbidity and mortality. Despite the benefits of HH treatment, glycemic control is often poor and neglected. The use of health applications to support diagnosis and therapy is now incorporated into medical practice. Medical applications for inpatient glycemic management have potential to standardize this handling by the nonspecialist physician. However, related studies are scarce. We aim to evaluate the efficacy in inpatient glycemic control parameters of medical software applications in non-critical care settings.

Methods

This systematic review on in-hospital insulin applications was performed according to PRISMA guidelines. Data were extracted in triplicate and methodological quality was verified. Specific outcomes of interest were glycemic control efficacy, hypoglycemia risk, length of in-hospital stay, integration with the electronic medical record and healthcare staff acceptance.

Results

Among the 573 articles initially identified and subsequent revision of the references of each one, seven studies involving six applications were eligible for the review. A better glycemic control was reported with the use of most in-hospital insulin applications in the studies evaluated, but there was no mention of the time to reach the glycemic goal. The risk of hypoglycemia was low. Different reasons influenced the varied acceptance of the use of applications among health professionals.

Conclusion

The six applications of inpatient insulin therapy in a non-critical care environment proved to be useful and safe compared to the usual management. Medical apps are tools that can help improve the quality of patient care.

What You Need to Know Before Implementing a Clinical Research Data Warehouse: Comparative Review of Integrated Data Repositories in Health Care Institutions

Background

Integrated data repositories (IDRs), also referred to as clinical data warehouses, are platforms used for the integration of several data sources through specialized analytical tools that facilitate data processing and analysis. IDRs offer several opportunities for clinical data reuse, and the number of institutions implementing an IDR has grown steadily in the past decade.

Objective

The architectural choices of major IDRs are highly diverse and determining their differences can be overwhelming. This review aims to explore the underlying models and common features of IDRs, provide a high-level overview for those entering the field, and propose a set of guiding principles for small- to medium-sized health institutions embarking on IDR implementation.

Methods

We reviewed manuscripts published in peer-reviewed scientific literature between 2008 and 2020, and selected those that specifically describe IDR architectures. Of 255 shortlisted articles, we found 34 articles describing 29 different architectures. The different IDRs were analyzed for common features and classified according to their data processing and integration solution choices.

Results

Despite common trends in the selection of standard terminologies and data models, the IDRs examined showed heterogeneity in the underlying architecture design. We identified 4 common architecture models that use different approaches for data processing and integration. These different approaches were driven by a variety of features such as data sources, whether the IDR was for a single institution or a collaborative project, the intended primary data user, and purpose (research-only or including clinical or operational decision making).

Conclusions

IDR implementations are diverse and complex undertakings, which benefit from being preceded by an evaluation of requirements and definition of scope in the early planning stage. Factors such as data source diversity and intended users of the IDR influence data flow and synchronization, both of which are crucial factors in IDR architecture planning.

Design and Development of Diabetes Management System Using Machine Learning

This paper describes the design and implementation of a software system to improve the management of diabetes using a machine learning approach and to demonstrate and evaluate its effectiveness in controlling diabetes. The proposed approach for this management system handles the various factors that affect the health of people with diabetes by combining multiple artificial intelligence algorithms. The proposed framework factors the diabetes management problem into subgoals: building a Tensorflow neural network model for food classification; thus, it allows users to upload an image to determine if a meal is recommended for consumption; implementing K-Nearest Neighbour (KNN) algorithm to recommend meals; using cognitive sciences to build a diabetes question and answer chatbot; tracking user activity, user geolocation, and generating pdfs of logged blood sugar readings. The food recognition model was evaluated with cross-entropy metrics that support validation using Neural networks with a backpropagation algorithm. The model learned features of the images fed from local Ghanaian dishes with specific nutritional value and essence in managing diabetics and provided accurate image classification with given labels and corresponding accuracy. The model achieved specified goals by predicting with high accuracy, labels of new images. The food recognition and classification model achieved over 95% accuracy levels for specific calorie intakes. The performance of the meal recommender model and question and answer chatbot was tested with a designed cross-platform user-friendly interface using Cordova and Ionic Frameworks for software development for both mobile and web applications. The system recommended meals to meet the calorific needs of users successfully using KNN (with k = 5) and answered questions asked in a human-like way. The implemented system would solve the problem of managing activity, dieting recommendations, and medication notification of diabetics.

Advanced Diabetes Management Using Artificial Intelligence and Continuous Glucose Monitoring Sensors

Wearable continuous glucose monitoring (CGM) sensors are revolutionizing the treatment of type 1 diabetes (T1D). These sensors provide in real-time, every 1-5 min, the current blood glucose concentration and its rate-of-change, two key pieces of information for improving the determination of exogenous insulin administration and the prediction of forthcoming adverse events, such as hypo-/hyper-glycemia. The current research in diabetes technology is putting considerable effort into developing decision support systems for patient use, which automatically analyze the patient's data collected by CGM sensors and other portable devices, as well as providing personalized recommendations about therapy adjustments to patients. Due to the large amount of data collected by patients with T1D and their variety, artificial intelligence (AI) techniques are increasingly being adopted in these decision support systems. In this paper, we review the state-of-the-art methodologies using AI and CGM sensors for decision support in advanced T1D management, including techniques for personalized insulin bolus calculation, adaptive tuning of bolus calculator parameters and glucose prediction.

Predictive analytics for blood glucose concentration: an empirical study using the tree-based ensemble approach

Purpose

The primary objective of this study was to recognize critical indicators in predicting blood glucose (BG) through data-driven methods and to compare the prediction performance of four tree-based ensemble models, i.e. bagging with tree regressors (bagging-decision tree [Bagging-DT]), AdaBoost with tree regressors (Adaboost-DT), random forest (RF) and gradient boosting decision tree (GBDT).

Design/methodology/approach

This study proposed a majority voting feature selection method by combining lasso regression with the Akaike information criterion (AIC) (LR-AIC), lasso regression with the Bayesian information criterion (BIC) (LR-BIC) and RF to select indicators with excellent predictive performance from initial 38 indicators in 5,642 samples. The selected features were deployed to build the tree-based ensemble models. The 10-fold cross-validation (CV) method was used to evaluate the performance of each ensemble model.

Findings

The results of feature selection indicated that age, corpuscular hemoglobin concentration (CHC), red blood cell volume distribution width (RBCVDW), red blood cell volume and leucocyte count are five most important clinical/physical indicators in BG prediction. Furthermore, this study also found that the GBDT ensemble model combined with the proposed majority voting feature selection method is better than other three models with respect to prediction performance and stability.

Practical implications

This study proposed a novel BG prediction framework for better predictive analytics in health care.

Social implications

This study incorporated medical background and machine learning technology to reduce diabetes morbidity and formulate precise medical schemes.

Originality/value

The majority voting feature selection method combined with the GBDT ensemble model provides an effective decision-making tool for predicting BG and detecting diabetes risk in advance.

A portfolio of biologic self-injection devices in rheumatology: how patient involvement in device design can improve treatment experience

Biologic drugs (e.g. anti-tumor necrosis factors) are effective treatments for multiple chronic inflammatory diseases including rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis. Administration of biologic drugs is usually via subcutaneous self-injection, which provides many patient benefits compared to infusions including increased flexibility, reduced costs, and reduced caregiver burden. However, it is also associated with challenges such as needle phobia, patient treatment misconceptions and incorrect drug administration, and can be impacted by dexterity problems. Evidence suggests these problems, along with other drug administration challenges (e.g. patient forgetfulness, busy lifestyles, and polypharmacy), can reduce patient adherence to treatment. To combat these challenges, patient feedback has been used to develop a range of self-injection devices, including pre-filled syringes, pre-filled pens, and electronic injection devices. Providing different devices for drug administration gives patients the opportunity to choose a device that addresses the challenges they face as an individual. Research suggests involving patients in medical device development, providing patients with a choice of devices and enrolling individuals in patient support programs can empower patients to take control of their treatment journey. By providing a portfolio of self-injection devices, designed based on patient needs, patient experience will improve, potentially improving adherence and hence, long-term treatment outcomes.

Artificial Intelligence for Diabetes Management and Decision Support: Literature Review

Background

Artificial intelligence methods in combination with the latest technologies, including medical devices, mobile computing, and sensor technologies, have the potential to enable the creation and delivery of better management services to deal with chronic diseases. One of the most lethal and prevalent chronic diseases is diabetes mellitus, which is characterized by dysfunction of glucose homeostasis.

Objective

The objective of this paper is to review recent efforts to use artificial intelligence techniques to assist in the management of diabetes, along with the associated challenges.

Methods

A review of the literature was conducted using PubMed and related bibliographic resources. Analyses of the literature from 2010 to 2018 yielded 1849 pertinent articles, of which we selected 141 for detailed review.

Results

We propose a functional taxonomy for diabetes management and artificial intelligence. Additionally, a detailed analysis of each subject category was performed using related key outcomes. This approach revealed that the experiments and studies reviewed yielded encouraging results.

Conclusions

We obtained evidence of an acceleration of research activity aimed at developing artificial intelligence-powered tools for prediction and prevention of complications associated with diabetes. Our results indicate that artificial intelligence methods are being progressively established as suitable for use in clinical daily practice, as well as for the self-management of diabetes. Consequently, these methods provide powerful tools for improving patients’ quality of life.

Comparison of Machine Learning Approaches Toward Assessing the Risk of Developing Cardiovascular Disease as a Long-Term Diabetes Complication

The estimation of long-term diabetes complications risk is essential in the process of medical decision making. Guidelines for the management of Type 2 Diabetes Mellitus (T2DM) advocate calculating the Cardiovascular Disease (CVD) risk to initiate appropriate treatment. The objective of this study is to investigate the use of sophisticated machine learning techniques toward the development of personalized models able to predict the risk of fatal or nonfatal CVD incidence in T2DM patients. The important challenge of handling the unbalanced nature of the available dataset is addressed by applying novel ensemble strategies. Hybrid Wavelet Neural Networks (HWNNs) and Self-Organizing Maps (SOMs) constitute the primary models for building ensembles following a subsampling approach. Different methods for combining the decisions of the primary models are applied and comparatively assessed. Data from the 5-year follow up of 560 patients with T2DM are used for development and evaluation purposes. The highest discrimination performance (Area Under the Curve (AUC): 71.48%) is achieved by taking into account both the HWNN- and SOM- based primary models' outputs. The proposed method is superior to the Binomial Linear Regression (BLR) model justifying the need to apply more sophisticated techniques in order to produce reliable CVD risk scores.

A Review of Emerging Technologies for the Management of Diabetes Mellitus

OBJECTIVE

High prevalence of diabetes mellitus (DM) along with the poor health outcomes and the escalated costs of treatment and care poses the need to focus on prevention, early detection and improved management of the disease. The aim of this paper is to present and discuss the latest accomplishments in sensors for glucose and lifestyle monitoring along with clinical decision support systems (CDSSs) facilitating self-disease management and supporting healthcare professionals in decision making.

METHODS

A critical literature review analysis is conducted focusing on advances in: 1) sensors for physiological and lifestyle monitoring, 2) models and molecular biomarkers for predicting the onset and assessing the progress of DM, and 3) modeling and control methods for regulating glucose levels.

RESULTS

Glucose and lifestyle sensing technologies are continuously evolving with current research focusing on the development of noninvasive sensors for accurate glucose monitoring. A wide range of modeling, classification, clustering, and control approaches have been deployed for the development of the CDSS for diabetes management. Sophisticated multiscale, multilevel modeling frameworks taking into account information from behavioral down to molecular level are necessary to reveal correlations and patterns indicating the onset and evolution of DM.

CONCLUSION

Integration of data originating from sensor-based systems and electronic health records combined with smart data analytics methods and powerful user centered approaches enable the shift toward preventive, predictive, personalized, and participatory diabetes care.

SIGNIFICANCE

The potential of sensing and predictive modeling approaches toward improving diabetes management is highlighted and related challenges are identified.

Comparative assessment of glucose prediction models for patients with type 1 diabetes mellitus applying sensors for glucose and physical activity monitoring

The present work presents the comparative assessment of four glucose prediction models for patients with type 1 diabetes mellitus (T1DM) using data from sensors monitoring blood glucose concentration. The four models are based on a feedforward neural network (FNN), a self-organizing map (SOM), a neuro-fuzzy network with wavelets as activation functions (WFNN), and a linear regression model (LRM), respectively. For the development and evaluation of the models, data from 10 patients with T1DM for a 6-day observation period have been used. The models' predictive performance is evaluated considering a 30-, 60- and 120-min prediction horizon, using both mathematical and clinical criteria. Furthermore, the addition of input data from sensors monitoring physical activity is considered and its effect on the models' predictive performance is investigated. The continuous glucose-error grid analysis indicates that the models' predictive performance benefits mainly in the hypoglycemic range when additional information related to physical activity is fed into the models. The obtained results demonstrate the superiority of SOM over FNN, WFNN, and LRM with SOM leading to better predictive performance in terms of both mathematical and clinical evaluation criteria.

Evaluation of short-term predictors of glucose concentration in type 1 diabetes combining feature ranking with regression models

Glucose concentration in type 1 diabetes is a function of biological and environmental factors which present high inter-patient variability. The objective of this study is to evaluate a number of features, which are extracted from medical and lifestyle self-monitoring data, with respect to their ability to predict the short-term subcutaneous (s.c.) glucose concentration of an individual. Random forests (RF) and RReliefF algorithms are first employed to rank the candidate feature set. Then, a forward selection procedure follows to build a glucose predictive model, where features are sequentially added to it in decreasing order of importance. Predictions are performed using support vector regression or Gaussian processes. The proposed method is validated on a dataset of 15 type diabetics in real-life conditions. The s.c. glucose profile along with time of the day and plasma insulin concentration are systematically highly ranked, while the effect of food intake and physical activity varies considerably among patients. Moreover, the average prediction error converges in less than d/2 iterations (d is the number of features). Our results suggest that RF and RReliefF can find the most informative features and can be successfully used to customize the input of glucose models.

Performance assessment of a closed-loop system for diabetes management

Telemedicine systems can play an important role in the management of diabetes, a chronic condition that is increasing worldwide. Evaluations on the consistency of information across these systems and on their performance in a real situation are still missing. This paper presents a remote monitoring system for diabetes management based on physiological sensors, mobile technologies and patient/doctor applications over a service-oriented architecture that has been evaluated in an international trial (83,905 operation records). The proposed system integrates three types of running environments and data engines in a single service-oriented architecture. This feature is used to assess key performance indicators comparing them with other type of architectures. Data sustainability across the applications has been evaluated showing better outcomes for full integrated sensors. At the same time, runtime performance of clients has been assessed spotting no differences regarding the operative environment.

Integration of Personalized Healthcare Pathways in an ICT Platform for Diabetes Managements: A Small-Scale Exploratory Study

The availability of new tools able to support patient monitoring and personalized care may substantially improve the quality of chronic disease management. A personalized healthcare pathway (PHP) has been developed for diabetes disease management and integrated into an information and communication technology system to accomplish a shift from organization-centered care to patient-centered care. A small-scale exploratory study was conducted to test the platform. Preliminary results are presented that shed light on how the PHP influences system usage and performance outcomes.

Monitoring and Assisting Maternity-Infant Care in Rural Areas (MAMICare)

Presented is the project called MAMICare, which is motivated by the alarming number of maternity and infant deaths in rural areas due mainly to a poor monitoring of pregnancy progress and lack of appropriate alerting mechanism in case of abnormal gestation evolution. This work proposes an information technology solution based on mobile devices, and health sensors such as ECG (electrocardiogram), stethoscope, pulse-oximeter, and blood-glucose meter to collect automatically relevant health data for a better monitoring of pregnant women. This article addresses the status of the maternity infant death problem especially in rural areas of Mexico. It reviews some applications of IT in health systems (known also as Electronic Health or simply e-Health) and discusses how these are related to the presented proposal and how they differ. The article presents the proposed solution and discuss the current status of the work.

Evaluating self-management behaviors of diabetic patients in a telehealthcare program: longitudinal study over 18 months

BACKGROUND

Self-management is an important skill for patients with diabetes, and it involves frequent monitoring of glucose levels and behavior modification. Techniques to enhance the behavior changes of diabetic patients have been developed, such as diabetes self-management education and telehealthcare. Although the patients are engaged in self-management activities, barriers to behavior changes remain and additional work is necessary to address the impact of electronic media and telehealthcare on patient self-care behaviors.

OBJECTIVE

The aims of this study were to (1) explore the behaviors of diabetic patients interacting with online applications, (2) determine the impact of a telehealthcare program among 7 self-care behaviors of the patients, and (3) determine the changes in glycosylated hemoglobin (HbA1c) levels.

METHODS

A telehealthcare program was conducted to assist the patients with 7 self-care activities. The telehealthcare program lasted for 18 months and included the use of a third-generation mobile telecommunications glucometer, an online diabetes self-management system, and a teleconsultant service. We analyzed the data of 59 patients who participated in the telehealthcare program and 103 who did not. The behavioral assessments and the HbA1c data were collected and statistically analyzed to determine whether the telehealthcare services had an impact on the patients. We divided the 18-month period into 3 6-month intervals and analyzed the parameters of patients assisted by the telehealthcare service at different time points. We also compared the results of those who were assisted by the telehealthcare service with those who were not.

RESULTS

There was a significant difference in monitoring blood glucose between the beginning and the end of the patient participation (P=.046) and between the overall period and the end of patient participation (P<.001). Five behaviors were significantly different between the intervention and control patients: being active (P<.001), healthy eating (P<.001), taking medication (P<.001), healthy coping (P=.02), and problem solving (P<.001). Monitoring of blood glucose was significantly different (P=.02) during the 6-12 month stage of patient participation between the intervention and control patients. A significant difference between the beginning and the 6-12 month stage of patient participation was observed for the mean value of HbA1c level (P=.02), and the differences between the overall HbA1c variability and the variability of each 6-month interval was also significant.

CONCLUSIONS

Telehealthcare had a positive effect on diabetic patients. This study had enhanced blood glucose monitoring, and the patients in the program showed improvements in glycemic control. The self-care behaviors affect patient outcomes, and the changes of behavior require time to show the effects.

'Patient-centered care' for complex patients with type 2 diabetes mellitus-analysis of two cases

Purpose

This paper serves to apply and compare aspects of person centered care and recent consensus guidelines to two cases of older adults with poorly controlled diabetes in the context of relatively similar multimorbidity.

Methods

After review of the literature regarding the shift from guidelines promoting tight control in diabetes management to individualized person centered care, as well as newer treatment approaches emerging in diabetes care, the newer guidelines and potential treatment approaches are applied to the cases.

Results

By delving into the clinical, behavioral, social, cultural and economic aspects of the two cases in applying the new guidelines, divergent care goals are reached for the cases.

Conclusions

Primary care practitioners must be vigilant in providing individualized diabetes treatment where multiple chronic illnesses increase the complexity of care. While two older adults with multimorbidity may appear at first to have similar care goals, their unique preferences and support systems, as well as their risks and benefits from tight control, must be carefully weighed in formulating the best approach. Newer pharmaceutical agents hold promise for improving the possibilities for better glycemic control with less self-care burden and risk of hypoglycemia.

A glucose model based on support vector regression for the prediction of hypoglycemic events under free-living conditions

BACKGROUND

The prevention of hypoglycemic events is of paramount importance in the daily management of insulin-treated diabetes. The use of short-term prediction algorithms of the subcutaneous (s.c.) glucose concentration may contribute significantly toward this direction. The literature suggests that, although the recent glucose profile is a prominent predictor of hypoglycemia, the overall patient's context greatly impacts its accurate estimation. The objective of this study is to evaluate the performance of a support vector for regression (SVR) s.c. glucose method on hypoglycemia prediction.

MATERIALS AND METHODS

We extend our SVR model to predict separately the nocturnal events during sleep and the non-nocturnal (i.e., diurnal) ones over 30-min and 60-min horizons using information on recent glucose profile, meals, insulin intake, and physical activities for a hypoglycemic threshold of 70 mg/dL. We also introduce herein additional variables accounting for recurrent nocturnal hypoglycemia due to antecedent hypoglycemia, exercise, and sleep. SVR predictions are compared with those from two other machine learning techniques.

RESULTS

The method is assessed on a dataset of 15 patients with type 1 diabetes under free-living conditions. Nocturnal hypoglycemic events are predicted with 94% sensitivity for both horizons and with time lags of 5.43 min and 4.57 min, respectively. As concerns the diurnal events, when physical activities are not considered, the sensitivity is 92% and 96% for a 30-min and 60-min horizon, respectively, with both time lags being less than 5 min. However, when such information is introduced, the diurnal sensitivity decreases by 8% and 3%, respectively. Both nocturnal and diurnal predictions show a high (>90%) precision.

CONCLUSIONS

Results suggest that hypoglycemia prediction using SVR can be accurate and performs better in most diurnal and nocturnal cases compared with other techniques. It is advised that the problem of hypoglycemia prediction should be handled differently for nocturnal and diurnal periods as regards input variables and interpretation of results.

An early warning system for hypoglycemic/hyperglycemic events based on fusion of adaptive prediction models

INTRODUCTION

Early warning of future hypoglycemic and hyperglycemic events can improve the safety of type 1 diabetes mellitus (T1DM) patients. The aim of this study is to design and evaluate a hypoglycemia/hyperglycemia early warning system (EWS) for T1DM patients under sensor-augmented pump (SAP) therapy.

METHODS

The EWS is based on the combination of data-driven online adaptive prediction models and a warning algorithm. Three modeling approaches have been investigated: (i) autoregressive (ARX) models, (ii) auto-regressive with an output correction module (cARX) models, and (iii) recurrent neural network (RNN) models. The warning algorithm performs postprocessing of the models' outputs and issues alerts if upcoming hypoglycemic/hyperglycemic events are detected. Fusion of the cARX and RNN models, due to their complementary prediction performances, resulted in the hybrid autoregressive with an output correction module/recurrent neural network (cARN)-based EWS.

RESULTS

The EWS was evaluated on 23 T1DM patients under SAP therapy. The ARX-based system achieved hypoglycemic (hyperglycemic) event prediction with median values of accuracy of 100.0% (100.0%), detection time of 10.0 (8.0) min, and daily false alarms of 0.7 (0.5). The respective values for the cARX-based system were 100.0% (100.0%), 17.5 (14.8) min, and 1.5 (1.3) and, for the RNN-based system, were 100.0% (92.0%), 8.4 (7.0) min, and 0.1 (0.2). The hybrid cARN-based EWS presented outperforming results with 100.0% (100.0%) prediction accuracy, detection 16.7 (14.7) min in advance, and 0.8 (0.8) daily false alarms.

CONCLUSION

Combined use of cARX and RNN models for the development of an EWS outperformed the single use of each model, achieving accurate and prompt event prediction with few false alarms, thus providing increased safety and comfort.

A data encryption solution for mobile health apps in cooperation environments

Background

Mobile Health (mHealth) proposes health care delivering anytime and anywhere. It aims to answer several emerging problems in health services, including the increasing number of chronic diseases, high costs on national health services, and the need to provide direct access to health services, regardless of time and place. mHealth systems include the use of mobile devices and apps that interact with patients and caretakers. However, mobile devices present several constraints, such as processor, energy, and storage resource limitations. The constant mobility and often-required Internet connectivity also exposes and compromises the privacy and confidentiality of health information.

Objective

This paper presents a proposal, construction, performance evaluation, and validation of a data encryption solution for mobile health apps (DE4MHA), considering a novel and early-proposed cooperation strategy. The goal was to present a robust solution based on encryption algorithms that guarantee the best confidentiality, integrity, and authenticity of users health information. In this paper, we presented, explained, evaluated the performance, and discussed the cooperation mechanisms and the proposed encryption solution for mHealth apps.

Methods

First, we designed and deployed the DE4MHA. Then two studies were performed: (1) study and comparison of symmetric and asymmetric encryption/decryption algorithms in an mHealth app under a cooperation environment, and (2) performance evaluation of the DE4MHA. Its performance was evaluated through a prototype using an mHealth app for obesity prevention and cares, called SapoFit. We then conducted an evaluation study of the mHealth app with cooperation mechanisms and the DE4MHA using real users and a real cooperation scenario. In 5 days, 5 different groups of 7 students selected randomly agreed to use and experiment the SapoFit app using the 7 devices available for trials.

Results

There were 35 users of SapoFit that participated in this study. The performance evaluation of the app was done using 7 real mobile devices in 5 different days. The results showed that confidentiality and protection of the users’ health information was guaranteed and SapoFit users were able to use the mHealth app with satisfactory quality. Results also showed that the app with the DE4MHA presented nearly the same results as the app without the DE4MHA. The performance evaluation results considered the probability that a request was successfully answered as a function of the number of uncooperative nodes in the network. The service delivery probability decreased with the increase of uncooperative mobile nodes. Using DE4MHA, it was observed that performance presented a slightly worse result. The service average was also slightly worse but practically insignificantly different than with DE4MHA, being considered negligible.

Conclusions

This paper proposed a data encryption solution for mobile health apps, called DE4MHA. The data encryption algorithm DE4MHA with cooperation mechanisms in mobile health allow users to safely obtain health information with the data being carried securely. These security mechanisms did not deteriorate the overall network performance and the app, maintaining similar performance levels as without the encryption. More importantly, it offers a robust and reliable increase of privacy, confidentiality, integrity, and authenticity of their health information. Although it was experimented on a specific mHealth app, SapoFit, both DE4MHA and the cooperation strategy can be deployed in other mHealth apps.

An information technology framework for strengthening telehealthcare service delivery

OBJECTIVE

Telehealthcare has been used to provide healthcare service, and information technology infrastructure appears to be essential while providing telehealthcare service. Insufficiencies have been identified, such as lack of integration, need of accommodation of diverse biometric sensors, and accessing diverse networks as different houses have varying facilities, which challenge the promotion of telehealthcare. This study designs an information technology framework to strengthen telehealthcare delivery.

MATERIALS AND METHODS

The proposed framework consists of a system architecture design and a network transmission design. The aim of the framework is to integrate data from existing information systems, to adopt medical informatics standards, to integrate diverse biometric sensors, and to provide different data transmission networks to support a patient's house network despite the facilities. The proposed framework has been evaluated with a case study of two telehealthcare programs, with and without the adoption of the framework.

RESULTS

The proposed framework facilitates the functionality of the program and enables steady patient enrollments. The overall patient participations are increased, and the patient outcomes appear positive. The attitudes toward the service and self-improvement also are positive.

CONCLUSIONS

The findings of this study add up to the construction of a telehealthcare system. Implementing the proposed framework further assists the functionality of the service and enhances the availability of the service and patient acceptances.

Smart health monitoring systems: an overview of design and modeling

Health monitoring systems have rapidly evolved during the past two decades and have the potential to change the way health care is currently delivered. Although smart health monitoring systems automate patient monitoring tasks and, thereby improve the patient workflow management, their efficiency in clinical settings is still debatable. This paper presents a review of smart health monitoring systems and an overview of their design and modeling. Furthermore, a critical analysis of the efficiency, clinical acceptability, strategies and recommendations on improving current health monitoring systems will be presented. The main aim is to review current state of the art monitoring systems and to perform extensive and an in-depth analysis of the findings in the area of smart health monitoring systems. In order to achieve this, over fifty different monitoring systems have been selected, categorized, classified and compared. Finally, major advances in the system design level have been discussed, current issues facing health care providers, as well as the potential challenges to health monitoring field will be identified and compared to other similar systems.

Virtual groups for patient WBAN monitoring in medical environments

Wireless body area networks (WBAN) provide a tremendous opportunity for remote health monitoring. However, engineering WBAN health monitoring systems encounters a number of challenges including efficient WBAN monitoring information extraction, dynamically fine tuning the monitoring process to suit the quality of data, and to allow the translation of high-level requirements of medical officers to low-level sensor reconfiguration. This paper addresses these challenges, by proposing an architecture that allows virtual groups to be formed between devices of patients, nurses, and doctors in order to enable remote analysis of WBAN data. Group formation and modification is performed with respect to patients' conditions and medical officers' requirements, which could be easily adjusted through high-level policies. We also propose, a new metric called the Quality of Health Monitoring, which allows medical officers to provide feedback on the quality of WBAN data received. The WBAN data gathered are transmitted to the virtual group members through an underlying environmental sensor network. The proposed approach is evaluated through a series of simulation.

Real-time adaptive models for the personalized prediction of glycemic profile in type 1 diabetes patients

BACKGROUND

Prediction of glycemic profile is an important task for both early recognition of hypoglycemia and enhancement of the control algorithms for optimization of insulin infusion rate. Adaptive models for glucose prediction and recognition of hypoglycemia based on statistical and artificial intelligence techniques are presented.

METHODS

We compared an autoregressive (AR) model using only glucose information, an AR model with external insulin input (ARX), and an artificial neural network (ANN) using both glucose and insulin information. Online adaptive models were used to account for the intra- and inter-subject variability of the population with diabetes. The evaluation of the predictive ability included prediction horizons (PHs) of 30 min and 45 min.

RESULTS

The AR model presented root mean square error (RMSE) values of 14.0-21.6 mg/dL and correlation coefficients (CCs) of 0.92-0.95 for PH=30 min and 23.2-35.9 mg/dL and 0.79-0.87, respectively, for PH=45 min. The respective values for the ARX models were slightly better (PH=30 min, 13.3-18.8 mg/dL and 0.94-0.96; PH=45 min, 22.8-29.4 mg/dL and 0.83-0.88). For the ANN, the RMSE values ranged from 2.8 to 6.3 mg/dL, and the CC was 0.99 for all cases and PHs. The sensitivity of hypoglycemia prediction was 78% for AR, 81% for ARX, and 96% for ANN for PH=30 min and 65%, 67%, and 95%, respectively, for PH=45 min. The corresponding specificities were 96%, 96%, and 99% for PH=30 min and 93%, 93%, and 99% for PH=45 min.

CONCLUSIONS

The ANN appears to be more appropriate for the prediction of glucose profile based on glucose and insulin data.

E-Health towards ecumenical framework for personalized medicine via Decision Support System

The purpose of the present manuscript is to present the advances performed in medicine using a Personalized Decision Support System (PDSS). The models used in Decision Support Systems (DSS) are examined in combination with Genome Information and Biomarkers to produce personalized result for each individual. The concept of personalize medicine is described in depth and application of PDSS for Cardiovascular Diseases (CVD) and Type-1 Diabetes Mellitus (T1DM) are analyzed. Parameters extracted from genes, biomarkers, nutrition habits, lifestyle and biological measurements feed DSSs, incorporating Artificial Intelligence Modules (AIM), to provide personalized advice, medication and treatment.

Mobile phone technologies and advanced data analysis towards the enhancement of diabetes self-management

Advances in the area of mobile and wireless communication for healthcare (m-Health) along with the improvements in information science allow the design and development of new patient-centric models for the provision of personalised healthcare services, increase of patient independence and improvement of patient's self-control and self-management capabilities. This paper comprises a brief overview of the m-Health applications towards the self-management of individuals with diabetes mellitus and the enhancement of their quality of life. Furthermore, the design and development of a mobile phone application for Type 1 Diabetes Mellitus (T1DM) self-management is presented. The technical evaluation of the application, which permits the management of blood glucose measurements, blood pressure measurements, insulin dosage, food/drink intake and physical activity, has shown that the use of the mobile phone technologies along with data analysis methods might improve the self-management of T1DM.